Document is current
Any future updates will be listed below
-
Authors
Shyu, Margaret https://orcid.org/0000-0002-6043-6282
Liu, Angela
Srikureja, Anya
Gregorian, Alison
Srisuwananukorn, Andrew
Tremblay, Douglas
Naymagon, Leonard
- License Information
-
More Information
Article History
Accepted: 2 April 2024
First Online: 21 April 2024
Statements and Declarations
: Douglas Tremblay receives contracted research funding paid to his institution from CTI Biopharma, Astellas Pharma and Gilead and consulting fees from CTI Biopharma, Novartis, AbbVie, Sierra Oncology, GSK and Cogent Biosciences. The authors have no other conflicts of interest to disclose.
